A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer

The Institute of Oncology, Arensia Exploratory Medicine, Chisinau

National Cancer Center (Korea), IlsandongGu GoyangSi

Pulau Pinang Hospital, George Town

Seoul National University Bundang Hospital, BundangGu SeongnamSi

The Catholic University of Korea, St Vincents Hospital, PaldalGu SuwonSi

Tengku Ampuan Afzan Hospital, Kuantan

Hrh Princess Maha Chakri Sirindhorn Medical Center (Srinakharinwirot University), Ongkharak

Hospital Universitario de Octubre, Madrid

Chungbuk National University Hospital, SeowonGu CheongjuSi

Centro Ricerche Cliniche Di Verona, Verona

Srinagarind Hospital (Khon Kaen University), Muang

Hospital Universitario Virgen Del Rocio, Seville

Chu Nantes Hopital Nord Laennec, SaintHerblain

Maharaj Nakorn Chiang Mai Hospital (Chiang Mai University), Muang

Institut Curie, Paris

Songklanagarind Hospital (Prince of Songkhla University), Hat Yai

Sarawak General Hospital, Kuching

The Fifth Medical Center of Chinese Pla General Hospital, Beijing

Harbin Medical University Cancer Hospital, Harbin

National Cancer Centre Singapore, Singapore

Affiliated Zhongshan Hospital of Fudan University, Shanghai

Shanghai East Hospital Branch Hospital, Shanghai

Shanghai Pulmonary Hospital, Shanghai

The First Affiliated Hospital of Soochow University, Suzhou

Nantong Tumor Hospital Branch North, Nantong

The Second Hospital of Anhui Medical University, Hefei

Jining No Peoples Hospital East Branch, Jining

Linyi Peoples Hospital, Linyi

Tianjin Medical University Cancer Institute and Hospital, Tianjin

Taizhou Hospital of Zhejiang, Taizhou

The First Affiliated Hospital of Nanchang University Branch Xianghu, Nanchang

Fujian Cancer Hospital, Fuzhou

Arensia Research Clinic At the Oncology Institute Prof Dr Ion Chiricu, ClujNapoca

Hubei Cancer Hospital, Wuhan

Henan Cancer Hospital, Zhengzhou

Valkyrie Clinical Trials, Los Angeles

Massachusetts General Hospital, Boston

Memorial Sloan Kettering Cancer Center Mskcc, New York

Providence Portland Medical Center, Portland

The University of Texas Md Anderson Cancer Center, Houston

Blacktown Cancer and Haematology Centre, Blacktown

Chris Obrien Lifehouse, Camperdown

Northern Beaches Hospital, Frenchs Forest

Port Macquarie Base Hospital, Port Macquarie

One Clinical Research, Nedlands

St John of God Health Care, Subiaco

Hospital de Amor Barretos, Barretos

Hospital Do Cancer de Londrina, Londrina

Centro Gaucho Integrado de Oncologia Hospital Mae de Deus, Porto Alegre

Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto, São José do Rio Preto

Icesp Instituto Do Cancer Do Estado de Sao Paulo Octavio Frias de Oliveira, São Paulo

Cross Cancer Institute, Edmonton

Affiliated Hospital of Hebei University, Baoding

Shanxi Provincial Cancer Hospital, Taiyuan

Arensia Exploratory Medicine Llc, Tbilisi

Regina Elena, Istituto Nazionale Dei Tumori, Ifo, Irccs, Roma

Institute of Oncology Bucharest Prof Dr Alexandru Trestioreanu, Bucureti

Samsung Medical Center, GangnamGu

Severance Hospital Yonsei University Health System, SeodaemunGu

Asan Medical Center, SongpaGu

Hospital Universitario Vall Dhebron, Barcelona